Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) (AC1107)
Cat.#: ACPP-1107
Specifications
Despition Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) for ELISA, SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence CD138 (Gln23-Gly254) + hFc (Glu99-Ala330) + 6×His Tag Molecular Weight 50.8 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag and 6×His Tag Applications ELISA, SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1488 Mouse CNTF Protein (AC1488) 5 µg inquiry ACPP-1027 Recombinant Human Ephrin A3 Protein (Fc Tag) (AC1027) 50 µg inquiry ACPP-1541 Human OTOR Protein (AC1541) 5 µg inquiry ACPP-1026 Recombinant Human Neuropilin 1 Protein (6×His Tag) (AC1026) 50 µg inquiry ACPP-1236 SOX2 Blocking Peptide (AC1236) 250 µg inquiry ACPP-1028 Recombinant Mouse IL-6 Protein (Fc Tag) (AC1028) 50 µg inquiry ACPP-1431 Human CNTFR Protein (AC1431) 5 µg inquiry ACPP-1646 Human DNAJB6 Protein (AC1646) 1 µg inquiry ACPP-1776 Human Acrp30 Protein, HMW (AC1776) 2 µg inquiry ACPP-1662 Human POFUT1 Protein (AC1662) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket